Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation - Top-Institutions - MDSpire

Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation

  • By

  • Yuqin Men

  • Chunyan Wang

  • David O. Popoola

  • Zhi Cao

  • Weikun Tian

  • Robert N. Cooney

  • Qinghe Meng

  • Yamin Li

  • May 29, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    SUNY Upstate Medical University
    SUNY Upstate Medical University

    Syracuse, NY

    Key Differentiators

    • Pulmonology
    • Pharmacology
    • Biochemistry

  • #2

    UT Southwestern Medical Center
    UT Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Pulmonology
    • Gene Therapy

Original Source(s)

Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation

  • by Yuqin Men, Chunyan Wang, David O. Popoola, Zhi Cao, Weikun Tian, Robert N. Cooney, Qinghe Meng, Yamin Li

  • May 29, 2026

Related Content

Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.